A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Volume 23, 2019 Articles
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
PreScription: The Cost of Information Allen Loyd V Jr	Jan/Feb 2019 Pg. 4
An Outlook on the European and Italian Rules to Guarantee Magistral Formulas Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola	Jan/Feb 2019 Pg. 6-12
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Williams LaVonn A	Jan/Feb 2019 Pg. 14-21
Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Zur Eyal	Jan/Feb 2019 Pg. 23-31
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A	Jan/Feb 2019 Pg. 32-33
Basics of Compounding: Standardization of Compounded Medications Allen Loyd V Jr	Jan/Feb 2019 Pg. 35-44
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Martin Matt	Jan/Feb 2019 Pg. 47-49
Calculations Stockton Shelly J	Jan/Feb 2019 Pg. 50
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Jan/Feb 2019 Pg. 52
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 53
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Allen Loyd V Jr	Jan/Feb 2019 Pg. 54
Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes Allen Loyd V Jr	Jan/Feb 2019 Pg. 55
Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary Allen Loyd V Jr	Jan/Feb 2019 Pg. 56
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 57
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Allen Loyd V Jr	Jan/Feb 2019 Pg. 58
Orodispersible Film Allen Loyd V Jr	Jan/Feb 2019 Pg. 59
Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation Allen Loyd V Jr	Jan/Feb 2019 Pg. 60
Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 61
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap	Jan/Feb 2019 Pg. 62-64
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson	Jan/Feb 2019 Pg. 65-69
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A	Jan/Feb 2019 Pg. 70-76
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C	Jan/Feb 2019 Pg. 77-81
Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream Shakshuki Ayah, Agu Remigius U	Jan/Feb 2019 Pg. 82-87
PreScription: Compounding with Cannabidiol Allen Loyd V Jr	Mar/Apr 2019 Pg. 92
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Zur Eyal	Mar/Apr 2019 Pg. 94-104
Nimodipine Compounded Oral Suspension: A True Documented Medical Need McElhiney Linda F	Mar/Apr 2019 Pg. 106-111
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Zur Eyal	Mar/Apr 2019 Pg. 113-119
Patient Access Is a Patient Safety Issue Pore David	Mar/Apr 2019 Pg. 120-121
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? Allen Loyd V Jr	Mar/Apr 2019 Pg. 123-130
Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations Allen Loyd V Jr	Mar/Apr 2019 Pg. 135-143
Calculations Stockton Shelly J, Drinnon Stephen D	Mar/Apr 2019 Pg. 144
Acetaminophen 50% Pluronic Lecithin Organogel Gel Allen Loyd V Jr	Mar/Apr 2019 Pg. 146
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 147
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Dexamethasone 2 mg/g Topical Paste, Veterinary Allen Loyd V Jr	Mar/Apr 2019 Pg. 149
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Mar/Apr 2019 Pg. 150
Perphenazine 0.5 mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2019 Pg. 151
Rosuvastatin 20-mg/5-mL Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 152
Tacrolimus 0.5 mg/mL in Oral Mix Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 153
Towards the Importance of a Roller Mill in Compounding Practice: An Experimental Approach Polonini Hudson, Loures da Silva Sharlene, Batista Patrício Fernando, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson	Mar/Apr 2019 Pg. 154-156
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A	Mar/Apr 2019 Pg. 157-162
Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Jamart Jacques, Bihin Benoît, Soumoy Laura, Hecq Jean-Daniel, Galanti Laurence M	Mar/Apr 2019 Pg. 163-166
Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure Ip Kendice, Banov Daniel, Bassani Gus, Morgan Latisha	Mar/Apr 2019 Pg. 167-175
PreScription: Honesty/Ethics in Professions: The Gallup Polls Allen Loyd V Jr	May/Jun 2019 Pg. 180
How to Develop and Maintain a Hazardous Drug List Dillon L Rad	May/Jun 2019 Pg. 182-186
Summary of Educational Offerings Provided by Compounding Support Companies in 2019 Stevens J Tyler	May/Jun 2019 Pg. 188-191
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Riepl Mike	May/Jun 2019 Pg. 192-199
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1 Zur Eyal	May/Jun 2019 Pg. 200-207
Can We Fix It? Brunner Scott	May/Jun 2019 Pg. 208-209
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing Allen Loyd V Jr	May/Jun 2019 Pg. 211-216
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Allen Loyd V Jr	May/Jun 2019 Pg. 221-228
Calculations Stockton Shelly J	May/Jun 2019 Pg. 229
Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension Allen Loyd V Jr	May/Jun 2019 Pg. 230
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2019 Pg. 231
Clopidogrel 5 mg/mL in a Sugar-Free Syrup Allen Loyd V Jr	May/Jun 2019 Pg. 232
Flunisolide Nasal Spray Allen Loyd V Jr	May/Jun 2019 Pg. 233
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2019 Pg. 234
Methotrexate 2-mg/mL Oral Solution Allen Loyd V Jr	May/Jun 2019 Pg. 235
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Allen Loyd V Jr	May/Jun 2019 Pg. 236
Valsartan 16-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2019 Pg. 237
Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J	May/Jun 2019 Pg. 238-244
Trends of Extemporaneous Drug Prescription in Latvia in 2017 Kiselova Olga, Maurina Baiba, Sidlovska Venta, Rogovska Irena	May/Jun 2019 Pg. 245-249
Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation Rashid Mamoon, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy	May/Jun 2019 Pg. 250-257
An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability Reindel Kristin L, DeAngelis Michael J, Ferrara Alexander S, Conn Kelly M, Phillips Elizabeth M, Corigliano Anthony T, Zhao Fang	May/Jun 2019 Pg. 258-263
PreScription: Temperatures by Degrees Allen Loyd V Jr	Jul/Aug 2019 Pg. 268
Contamination Control in Compounding Areas Mulder Kyle, Gonzales Ben A	Jul/Aug 2019 Pg. 271-278
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations Newton David W	Jul/Aug 2019 Pg. 281-287
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2 Zur Eyal	Jul/Aug 2019 Pg. 288-293
Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future Brunner Scott	Jul/Aug 2019 Pg. 294-296
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing Allen Loyd V Jr	Jul/Aug 2019 Pg. 299-303
Basics: Excipients Used in Nonsterile Compounding, Part 1 Allen Loyd V Jr	Jul/Aug 2019 Pg. 305-311
Calculations Stockton Shelly J, Drinnon Stephen D	Jul/Aug 2019 Pg. 312-313
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension Allen Loyd V Jr	Jul/Aug 2019 Pg. 314
Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Allen Loyd V Jr	Jul/Aug 2019 Pg. 315
Domperidone 5 mg/mL in Oral Mix Allen Loyd V Jr	Jul/Aug 2019 Pg. 316
Lorazepam 1 mg/mL in Anhydrous Organic Solvent System Allen Loyd V Jr	Jul/Aug 2019 Pg. 317
Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes Allen Loyd V Jr	Jul/Aug 2019 Pg. 318
Rifampin 25 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2019 Pg. 319
Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit Lardinois Benjamin, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence	Jul/Aug 2019 Pg. 320-323
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro	Jul/Aug 2019 Pg. 324-331
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy Glaser Rebecca L, York Anne E	Jul/Aug 2019 Pg. 325-339
Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches Burrows Anna C, Yellepeddi Venkata Kashyap, Snyder Spencer, Wakefield Meagan, Jackson David, Huynh Johnny, Nguyen Khoa, Sayre Casey L	Jul/Aug 2019 Pg. 340-350
Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104.	Jul/Aug 2019 Pg. 351
Erratum: Kiselova O, Maurina B, Sidlovska V et al. Trends of Extemporaneous Drug Prescription in Latvia in 2017. IJPC 2019; 23(3): 245-249.	Jul/Aug 2019 Pg. 351
PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc Allen Loyd V Jr	Sep/Oct 2019 Pg. 356
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Pope George, Daleo Charles, Batson SL	Sep/Oct 2019 Pg. 358-364
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Zur Eyal	Sep/Oct 2019 Pg. 366-375
Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Zur Eyal	Sep/Oct 2019 Pg. 376-381
Threading the Needle Brunner Scott	Sep/Oct 2019 Pg. 383-385
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R	Sep/Oct 2019 Pg. 387-391
Basics: Excipients Used in Nonsterile Compounding, Part 2 Allen Loyd V Jr	Sep/Oct 2019 Pg. 393-396
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Allen Loyd V Jr	Sep/Oct 2019 Pg. 399-402
Calculations Stockton Shelly J	Sep/Oct 2019 Pg. 404
Allopurinol 20 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2019 Pg. 406
Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2019 Pg. 407
Dipyridamole 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2019 Pg. 408
Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Allen Loyd V Jr	Sep/Oct 2019 Pg. 409
Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2019 Pg. 410
Sorafenib Capsules for Pediatric Use Allen Loyd V Jr	Sep/Oct 2019 Pg. 411
Valsartan 4 mg/mL in Vehicle for Oral Solution USP Allen Loyd V Jr	Sep/Oct 2019 Pg. 412
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Allen Loyd V Jr	Sep/Oct 2019 Pg. 413
Stability of Furosemide 5 mg/mL in Polypropylene Syringes van der Schaar JAJ, Grouls R, Franssen EJF, Crul M	Sep/Oct 2019 Pg. 414-417
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián	Sep/Oct 2019 Pg. 418-421
The Current Landscape of Veterinary Compounding in the Pharmacy Setting Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R	Sep/Oct 2019 Pg. 422-427
The Current Landscape of Veterinary Compounding in the Veterinary Setting Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R	Sep/Oct 2019 Pg. 428-433
Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics Lardinois Benjamin, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence	Sep/Oct 2019 Pg. 434-437
Erratum: McNulty JP, Hahn K. Compounded oral ketamine for severe depression, anxiety, and pain in a hospice patient with end-stage chronic obstructive pulmonary disease, cardiopulmonary failure, and severe : A case report. IJPC. 2012; 16(5): 364–368.	Sep/Oct 2019 Pg. 438
Erratum: Stevens JT. Summary of educational offerings provided by compounding support companies in 2019. IJPC. 2019; 23(3): 188–191.	Sep/Oct 2019 Pg. 438
PreScription: As Things Change…. Allen Loyd V Jr	Nov/Dec 2019 Pg. 444
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators Mulder Kyle	Nov/Dec 2019 Pg. 447-452
How to Qualify Container Closure Systems for Intended Use, Part 1 Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page	Nov/Dec 2019 Pg. 454-461
Are You Part of the Solution or Part of the Problem? Brunner Scott	Nov/Dec 2019 Pg. 462-464
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R	Nov/Dec 2019 Pg. 467-471
Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives Allen Loyd V Jr	Nov/Dec 2019 Pg. 472-477
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Allen Loyd V Jr	Nov/Dec 2019 Pg. 478-482
Calculations Stockton Shelly J, Stover Emily M	Nov/Dec 2019 Pg. 484
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 486
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 488
Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 489
Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 490
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 491
Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) Allen Loyd V Jr	Nov/Dec 2019 Pg. 492
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 493
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Allen Loyd V Jr	Nov/Dec 2019 Pg. 494
Zonisamide 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 495
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Shakshuki Ayah, Agu Remigius U	Nov/Dec 2019 Pg. 496-503
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G	Nov/Dec 2019 Pg. 504-510
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control Hutson Chad, Day A J	Nov/Dec 2019 Pg. 511-518
Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V	Nov/Dec 2019 Pg. 519-527
Return to Top